Literature DB >> 1746289

Reliability and validity of the Chinese versions of the Scales for Assessment of Positive and Negative Symptoms.

M R Phillips1, W Xiong, R W Wang, Y H Gao, X Q Wang, N P Zhang.   

Abstract

This 4-center study assesses the reliability and validity of the Chinese versions of the Scale for Assessment of Positive Symptoms and the Scale for Assessment of Negative Symptoms. Interrater reliability, short-term test-retest reliability, and internal consistency were excellent; intraclass correlation coefficients and Cronbach alphas for the overall scores were all over 0.8. The strong correlation of the scales with an independently assessed parallel measure (the Chinese version of the Brief Psychiatric Rating Scale) and the separate positive and negative factors found with principal components analysis confirm the construct validity of the instruments. These findings demonstrate the importance of culturally sensitive revision and rigorous psychometric evaluation of Western instruments prior to their use in non-Western cultures.

Mesh:

Year:  1991        PMID: 1746289     DOI: 10.1111/j.1600-0447.1991.tb03161.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  12 in total

Review 1.  Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis.

Authors:  Rina Dutta; Talya Greene; Jean Addington; Kwame McKenzie; Michael Phillips; Robin M Murray
Journal:  Schizophr Bull       Date:  2007-06-11       Impact factor: 9.306

2.  Rater evaluations for psychiatric instruments and cultural differences: the positive and negative syndrome scale in China and the United States.

Authors:  Neil Krishan Aggarwal; Xiang Yang Zhang; Elina Stefanovics; Da Chun Chen; Mei Hong Xiu; Ke Xu; Robert A Rosenheck
Journal:  J Nerv Ment Dis       Date:  2012-09       Impact factor: 2.254

3.  Neurocognitive abnormalities during comprehension of real-world goal-directed behaviors in schizophrenia.

Authors:  Tatiana Sitnikova; Donald Goff; Gina R Kuperberg
Journal:  J Abnorm Psychol       Date:  2009-05

4.  Characteristics, experience, and treatment of schizophrenia in China.

Authors:  M R Phillips
Journal:  Dialogues Clin Neurosci       Date:  2001-06       Impact factor: 5.986

5.  Correlation between insight and internalized stigma in patients with schizophrenia.

Authors:  Ying Lu; Xiaoping Wang
Journal:  Shanghai Arch Psychiatry       Date:  2012-04

6.  Mismatch Negativity to Threatening Voices Associated with Positive Symptoms in Schizophrenia.

Authors:  Chenyi Chen; Chia-Chien Liu; Pei-Yuan Weng; Yawei Cheng
Journal:  Front Hum Neurosci       Date:  2016-07-15       Impact factor: 3.169

7.  Stereopsis deficits in patients with schizophrenia in a Han Chinese population.

Authors:  Li Hui; Hai Sen Xia; An Shu Tang; Yi Feng Zhou; Guang Zhong Yin; Xing Long Hu; Xiang Dong Du; Yong Tang
Journal:  Sci Rep       Date:  2017-04-12       Impact factor: 4.379

8.  Comparison of Olanzapine versus Other Second-Generation Antipsychotics in the Improvement of Insight and Medication Discontinuation Rate in Schizophrenia.

Authors:  Hongbo He; Yanling Zhou; Mingzhe Yang; Xiongxiong Li; Yu-Tao Xiang; Jiandong Luo
Journal:  Shanghai Arch Psychiatry       Date:  2018-06-25

9.  Risk perception in paranoia and anxiety: Two investigations across clinical and non-clinical populations.

Authors:  Suzanne Ho-Wai So; Xiaoqi Sun; Gloria Hoi Kei Chan; Iris Hiu Hung Chan; Chui De Chiu; Sherry Kit Wa Chan; Wai Yin Elisabeth Wong; Patrick Wing-Leung Leung; Eric Yu Hai Chen
Journal:  Schizophr Res Cogn       Date:  2020-03-29

10.  Morphological Profiling of Schizophrenia: Cluster Analysis of MRI-Based Cortical Thickness Data.

Authors:  Yunzhi Pan; Weidan Pu; Xudong Chen; Xiaojun Huang; Yan Cai; Haojuan Tao; Zhiming Xue; Michael Mackinley; Roberto Limongi; Zhening Liu; Lena Palaniyappan
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.